Xie Juhua & family

Early Life

Information regarding Xie Juhua's early life is not widely available. However, her current status and success indicate a dedicated career path within the pharmaceutical industry.

Rise to Success

Xie Juhua's primary source of wealth stems from her involvement with Kingfriend, a pharmaceuticals supplier. She is a director and the largest individual shareholder in the company. Kingfriend's main products include cardiovascular and anti-tumor drugs. Her son, Tang Yongqun, currently chairs the company, demonstrating a family's continued dedication to the business and the pharmaceutical industry.

Key Business Strategies

The success of Xie Juhua and her family can be attributed to their strategic focus on the pharmaceutical sector, specifically in the production of crucial drugs. This focus has led to significant financial success. Furthermore, her involvement as a director and shareholder indicates strong leadership.

Philanthropy

Specific details of Xie Juhua's philanthropic activities are not readily available.